Synthesis and Topoisomerase I Inhibitory Properties of Klavuzon Derivatives
| dc.contributor.author | Akçok, İsmail | |
| dc.contributor.author | Mete, Derya | |
| dc.contributor.author | Şen, Ayhan | |
| dc.contributor.author | Kasaplar, Pınar | |
| dc.contributor.author | Korkmaz, Kemal S. | |
| dc.contributor.author | Çağır, Ali | |
| dc.coverage.doi | 10.1016/j.bioorg.2017.02.012 | |
| dc.date.accessioned | 2017-10-17T08:18:21Z | |
| dc.date.available | 2017-10-17T08:18:21Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Klavuzon is a naphthalen-1-yl substituted α,β-unsaturated δ-lactone derivative, and is one of the anti-proliferative members of this class of compounds. Asymmetric and racemic syntheses of novel α,β-unsaturated δ-lactone derivatives are important to investigate their potential for the treatment of cancer. In this study, asymmetric and racemic syntheses of heteroatom-substituted klavuzon derivatives are reported. The syntheses were completed by a well-known three-step procedure. Anti-proliferative activity of seven novel racemic klavuzon derivatives were reported against MCF-7, PC3, HCT116 p53+/+ and HCT116 p53−/− cancer cell lines. Topoisomerase I inhibitory properties of 5,6-dihydro-2H-pyran-2-one derivatives were also studied. © 2017 Elsevier Inc. | en_US |
| dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK 110T782) | en_US |
| dc.identifier.citation | Akçok, İ., Mete, D., Şen, A., Kasaplar, P., Korkmaz, K. S., and Çağır, A. (2017). Synthesis and Topoisomerase I inhibitory properties of klavuzon derivatives. Bioorganic Chemistry, 71, 275-284. doi:10.1016/j.bioorg.2017.02.012 | en_US |
| dc.identifier.doi | 10.1016/j.bioorg.2017.02.012 | en_US |
| dc.identifier.doi | 10.1016/j.bioorg.2017.02.012 | |
| dc.identifier.issn | 0045-2068 | |
| dc.identifier.issn | 0045-2068 | |
| dc.identifier.scopus | 2-s2.0-85013638405 | |
| dc.identifier.uri | http://doi.org/10.1016/j.bioorg.2017.02.012 | |
| dc.identifier.uri | https://hdl.handle.net/11147/6369 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Ltd. | en_US |
| dc.relation | info:eu-repo/grantAgreement/TUBITAK/TBAG/110T782 | en_US |
| dc.relation.ispartof | Bioorganic Chemistry | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Klavuzon | en_US |
| dc.subject | Topoisomerase I inhibition | en_US |
| dc.subject | Anti-proliferative activity | en_US |
| dc.subject | Lactones | en_US |
| dc.title | Synthesis and Topoisomerase I Inhibitory Properties of Klavuzon Derivatives | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Akçok, İsmail | |
| gdc.author.institutional | Mete, Derya | |
| gdc.author.institutional | Şen, Ayhan | |
| gdc.author.institutional | Kasaplar, Pınar | |
| gdc.author.institutional | Çağır, Ali | |
| gdc.author.yokid | 113963 | |
| gdc.author.yokid | 110975 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Bioengineering | en_US |
| gdc.description.department | İzmir Institute of Technology. Chemistry | en_US |
| gdc.description.endpage | 284 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 275 | en_US |
| gdc.description.volume | 71 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W2590002157 | |
| gdc.identifier.pmid | 28242062 | |
| gdc.identifier.wos | WOS:000404534300027 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.downloads | 0 | |
| gdc.oaire.impulse | 6.0 | |
| gdc.oaire.influence | 2.840635E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Klavuzon | |
| gdc.oaire.keywords | alpha,beta-Unsaturated delta-lactone | |
| gdc.oaire.keywords | Antineoplastic Agents | |
| gdc.oaire.keywords | Topoisomerase I inhibition | |
| gdc.oaire.keywords | Lactones | |
| gdc.oaire.keywords | Structure-Activity Relationship | |
| gdc.oaire.keywords | DNA Topoisomerases, Type I | |
| gdc.oaire.keywords | Cell Line, Tumor | |
| gdc.oaire.keywords | Neoplasms | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Topoisomerase I Inhibitors | |
| gdc.oaire.keywords | Anti-proliferative activity | |
| gdc.oaire.keywords | Cell Proliferation | |
| gdc.oaire.popularity | 2.2016626E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 01 natural sciences | |
| gdc.oaire.sciencefields | 0104 chemical sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.views | 5 | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.80168826 | |
| gdc.openalex.normalizedpercentile | 0.66 | |
| gdc.opencitations.count | 7 | |
| gdc.plumx.crossrefcites | 6 | |
| gdc.plumx.mendeley | 11 | |
| gdc.plumx.scopuscites | 8 | |
| gdc.scopus.citedcount | 8 | |
| gdc.wos.citedcount | 8 | |
| relation.isAuthorOfPublication.latestForDiscovery | 48c272de-4658-4fcf-a8f8-fb4d3ca3abc4 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4003-8abe-a4dfe192da5e |
Collections
Chemistry / Kimya
Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
